Cargando…

Protein kinase A-mediated Phosphorylation Regulates STAT3 Activation and Oncogenic EZH2 Activity

Polycomb Repressive Complex 2 (PRC2) member enhancer of zeste homologue 2 (EZH2) trimethylates histone H3 lysine 27 (H3K27me3), alters chromatin structure and contributes to epigenetic regulation of gene expression in normal and disease processes. Phosphorylation of EZH2 augmented EZH2 oncogenic act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Özeş, Ali R., Pulliam, Nick, Ertosun, Mustafa G., Yılmaz, Özlem, Tang, Jessica, Çopuroğlu, Ece, Matei, Daniela, Özeş, Osman N., Nephew, Kenneth P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023775/ https://www.ncbi.nlm.nih.gov/pubmed/29576612 http://dx.doi.org/10.1038/s41388-018-0218-z

Ejemplares similares

Regulation of E2F1 activity via PKA-mediated phosphorylations
por: ERTOSUN, Mustafa Gökhan, et al.
Publicado: (2020)

AKT-mediated phosphorylation of TWIST1 is essential for breast cancer cell metastasis
por: ERTOSUN, Mustafa Gökhan, et al.
Publicado: (2020)

NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer
por: Özeş, Ali R., et al.
Publicado: (2016)

Positive regulation of TNFR1 signaling via SH3 recognition motif
por: ÇOPUROĞLU, Fatma Ece, et al.
Publicado: (2021)

3D culture adds an extra dimension to targeted epigenetic therapies
por: Ozes, Ali R, et al.
Publicado: (2013)

Therapeutic targeting using tumor specific peptides inhibits long non-coding RNA HOTAIR activity in ovarian and breast cancer
por: Özeş, Ali R., et al.
Publicado: (2017)

Identification of novel mutations of Insulin Receptor Substrate 1 (IRS1) in tumor samples of non-small cell lung cancer (NSCLC): Implications for aberrant insulin signaling in development of cancer
por: Gorgisen, Gokhan, et al.
Publicado: (2019)

EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells
por: Cardenas, Horacio, et al.
Publicado: (2016)

Mediator Kinase Phosphorylation of STAT1 S727 Promotes Growth of Neoplasms With JAK-STAT Activation
por: Nitulescu, Ioana I., et al.
Publicado: (2017)

Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors
por: Lee, Matilda, et al.
Publicado: (2018)

TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer
por: Versemann, Lennart, et al.
Publicado: (2022)

AAV1.NT-3 gene therapy prevents age-related sarcopenia
por: Ozes, Burcak, et al.
Publicado: (2023)

AAV1.NT‐3 gene therapy in the SOD1KO mouse model of accelerated sarcopenia
por: Tong, Lingying, et al.
Publicado: (2023)

EZH2 Exacerbates Breast Cancer by Methylating and Activating STAT3 Directly
por: Zhao, Yi, et al.
Publicado: (2021)

Asymmetric kinase dimer formation is crucial for the activation of oncogenic EGFRvIII but not for ERBB3 phosphorylation
por: Kancha, Rama Krishna, et al.
Publicado: (2013)

Linking JNK-STAT3-Akt signaling axis to EZH2 phosphorylation: A novel pathway of carcinogenesis
por: Rojanasakul, Yon
Publicado: (2013)

Aplasia Ras Homologous Member I Gene and Development of Glial Tumors
por: Yakut, S, et al.
Publicado: (2011)

AAV1.NT-3 gene therapy in a CMT2D model: phenotypic improvements in Gars(P278KY/+) mice
por: Ozes, Burcak, et al.
Publicado: (2021)

O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies
por: Freund, P, et al.
Publicado: (2017)

Screening for serine/threonine kinases phosphorylating Stat5
por: Berger, Angelika, et al.
Publicado: (2011)

Cyclin-dependent kinase 1-mediated phosphorylation of SET at serine 7 is essential for its oncogenic activity
por: Yin, Ling, et al.
Publicado: (2019)

S6K1-mediated phosphorylation of PDK1 impairs AKT kinase activity and oncogenic functions
por: Jiang, Qiwei, et al.
Publicado: (2022)

Modulatory role of phospholipase D in the activation of signal transducer and activator of transcription (STAT)-3 by thyroid oncogenic kinase RET/PTC
por: Kim, Young-Rae, et al.
Publicado: (2008)

Phosphorylation promotes activation-induced cytidine deaminase activity at the Myc oncogene
por: Mu, Yunxiang, et al.
Publicado: (2017)

LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer
por: Wang, Dejie, et al.
Publicado: (2015)

Stat1 Phosphorylation Determines Ras Oncogenicity by Regulating p27(Kip1)
por: Wang, Shuo, et al.
Publicado: (2008)

EZH2 Promotes T Follicular Helper Cell Differentiation Through Enhancing STAT3 Phosphorylation in Patients With Primary Sjögren’s Syndrome
por: He, Chengmei, et al.
Publicado: (2022)

Loss of EZH2 results in precocious mammary gland development and activation of STAT5-dependent genes
por: Yoo, Kyung Hyun, et al.
Publicado: (2015)

STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer
por: Pan, Yuan-Ming, et al.
Publicado: (2016)

EZH2 enhances the invasive capability of renal cell carcinoma cells via activation of STAT3
por: Zhang, Dong, et al.
Publicado: (2018)

SIK2 attenuates proliferation and survival of breast cancer cells with simultaneous perturbation of MAPK and PI3K/Akt pathways
por: Zohrap, Neslihan, et al.
Publicado: (2018)

Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma
por: Vanden Bempt, Marlies, et al.
Publicado: (2022)

Emerging Roles of LncRNAs in the EZH2-regulated Oncogenic Network
por: Hao, Aixin, et al.
Publicado: (2021)

TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma
por: Lv, Deguan, et al.
Publicado: (2017)

Protein Inhibitor of Activated STAT (PIAS) Negatively Regulates the JAK/STAT Pathway by Inhibiting STAT Phosphorylation and Translocation
por: Niu, Guo-Juan, et al.
Publicado: (2018)

MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling
por: Park, Jino, et al.
Publicado: (2016)

EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer
por: Zoma, Marita, et al.
Publicado: (2021)

p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor
por: Testoni, B, et al.
Publicado: (2011)

CDK1 phosphorylation of TAZ in mitosis inhibits its oncogenic activity
por: Zhang, Lin, et al.
Publicado: (2015)

Eriocalyxin B Inhibits STAT3 Signaling by Covalently Targeting STAT3 and Blocking Phosphorylation and Activation of STAT3
por: Yu, Xiaokui, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8253p76in5q2ganvo6dlcmn7f3